For nearly a decade, healthcare organizations have been investing in innovative digital health companies to unlock value and spur growth. And Accenture analysis shows funding is even higher now than forecasted two years ago. But investors today are more discriminating: they are strategic about the scale and timing of investments and keen to prioritize affordability. While failure is often more common than success with corporate venture investments, there are reasons to believe that payers and providers that linger on the sidelines of innovation do so at their peril.